Abstract
It has been reported that circ-ATAD1 promotes the development of gastric cancer. This study was carried out to analyze the role of circ-ATAD1 in endometrial cancer (EC). EC and paired non-tumor tissues from EC patients (n = 60) were subjected to the isolation of total RNA and RT-qPCR to analyze the expression of circ-ATAD1 and miR-10a. Correlations between circ-ATAD1 and miR-10a were analyzed by Pearson’s correlation coefficient. The effects of circ-ATAD1 overexpression on miR-10a expression and methylation were analyzed by RT-qPCR and methylation-specific PCR (MSP). The roles of circ-ATAD1 and miR-10a in regulating EC cell invasion and migration were analyzed by Transwell assays. We found that circ-ATAD1 was downregulated in EC, while miR-10a was upregulated in EC. An inverse correlation between circ-ATAD1 and miR-10a was observed across EC samples. In EC cells, circ-ATAD1 overexpression decreased miR-10a expression and increased miR-10a gene methylation. Transwell assay analysis showed that circ-ATAD1 overexpression totally reversed the enhancing effects of miR-10a on EC cell invasion and migration. Circ-ATAD1 is downregulated in EC and may suppress EC cell invasion and migration by downregulating miR-10a through methylation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Change history
19 June 2023
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s00335-023-10007-2
References
Busch EL et al (2017) Endometrial cancer risk factors, hormone receptors, and mortality prediction cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive. Oncology 26:727–735. https://doi.org/10.1158/1055-9965.Epi-16-0821
Chen YH, Song Y, Yu YL, Cheng W, Tong X (2019) miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism. Oncol Lett 17:5441–5446. https://doi.org/10.3892/ol.2019.10257
Constantine G, Kessler G, Graham S, Goldstein S (2018) Increased incidence of endometrial cancer following the women’s health initiative: an assessment of risk factors. J Women’s Health. https://doi.org/10.1089/jwh.2018.6956
Hudson J et al (2013) Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma. Exp Mol Pathol 95:62–67. https://doi.org/10.1016/j.yexmp.2013.05.001
Lee YT, Tan YJ, Oon C (2018) Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol 834:188. https://doi.org/10.1016/j.ejphar.2018.07.034
Lei B, Tian Z, Fan W, Ni B (2019) Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci 16:292–301. https://doi.org/10.7150/ijms.28047
Lheureux S, Oza AM (2016) Endometrial cancer—targeted therapies myth or reality? Review of current targeted treatments. Eur J Cancer 59:99–108. https://doi.org/10.1016/j.ejca.2016.02.016
Liu Y et al (2017) miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis. Cell Death Dis 8:e2739. https://doi.org/10.1038/cddis.2017.61
McDonald ME, Bender DP (2019) Endometrial cancer: obesity, genetics, and targeted agents. Obstet Gynecol Clin North Am 46:89–105. https://doi.org/10.1016/j.ogc.2018.09.006
Mitamura T, Dong P, Ihira K, Kudo M, Watari H (2019) Molecular-targeted therapies and precision medicine for endometrial cancer. Jpn J Clin Oncol 49:108–120. https://doi.org/10.1093/jjco/hyy159
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E (2016) Endometrial cancer. Lancet (london, England) 387:1094–1108. https://doi.org/10.1016/s0140-6736(15)00130-0
Scott OW, Tin Tin S, Bigby SM, Elwood JM (2019) Rapid increase in endometrial cancer incidence and ethnic differences in New Zealand. Cancer Causes Control 30:121–127. https://doi.org/10.1007/s10552-019-1129-1
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551
Sullivan SA et al (2018) SPR965, a PI3K/mTORC1/2 inhibitor, as a targeted therapy in endometrial cancer. Gynecol Oncol 149:171. https://doi.org/10.1016/j.ygyno.2018.04.389
Vo J et al (2019) The landscape of circular RNA in cancer. Cell 176:869-881.e813. https://doi.org/10.1016/j.cell.2018.12.021
Xiong D-d et al (2018) A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Trans Med 16:220. https://doi.org/10.1186/s12967-018-1593-5
Zhang L, Chang X, Zhai T, Yu J, Wang W, Du A, Liu N (2020) A novel circular RNA, circ-ATAD1, contributes to gastric cancer cell progression by targeting miR-140–3p/YY1/PCIF1 signaling axis. Biochem Biophy Res Commun 525:841–849. https://doi.org/10.1016/j.bbrc.2020.02.100
Zhao ZJ, Shen J (2017) Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol 14:514–521. https://doi.org/10.1080/15476286.2015.1122162
Author information
Authors and Affiliations
Contributions
PXY and KLY: clinical studies, experiments work, data analysis, and manuscript writing. RYZ: literature research, experiment design, and manuscript revision. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Ethical approval
This study was approved by the Ethics Committee of Affiliated Hospital of Inner Mongolia Medical University.
Informed consent
All the patients signed written informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1007/s00335-023-10007-2
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yang, P., Yun, K. & Zhang, R. RETRACTED ARTICLE: CircRNA circ-ATAD1 is downregulated in endometrial cancer and suppresses cell invasion and migration by downregulating miR-10a through methylation. Mamm Genome 32, 488–494 (2021). https://doi.org/10.1007/s00335-021-09899-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-021-09899-9